Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Importance of the Topic

Glycan structures significantly influence antibody functions and pharmaceutical quality. N-linked glycans modulate mechanisms such as ADCC and CDC, making precise glycan control essential for therapeutic antibody development and ensuring safety and efficacy.

Objectives and Overview

This study aimed to perform a multifaceted evaluation of glycosyltransferase reactions affecting IgG glycan profiles by monitoring substrate precursors (sugars), cofactors (metal ions), sugar nucleotides, and glycan products under varied cell culture conditions with manganese and galactose supplementation.

Methodology and Instrumentation

The workflow included parallel analyses of culture supernatants and cell pellets:

• Metal ion quantification by ICPMS-2050 with 20-fold dilution in nitric/hydrochloric acid solution to measure Mn levels.
• Sugar analysis in supernatant using LCMS-8060NX after protein removal by acetonitrile precipitation and 10-fold dilution.
• Intracellular sugar and sugar nucleotide profiling via LCMS-8060 following cold methanol/water extraction and centrifugal evaporation.
• Antibody glycan profiling in supernatant using EZGlyco mAb-N Kit with 2-AB labeling and HPLC-RF detection on Nexera XR with Shim-pack GIST-HP Amide column.

Main Results and Discussion

• Cell viability and growth profiles remained consistent across control and supplemented cultures, indicating no cytotoxic effects from Mn/galactose addition.
• Mn uptake per cell increased significantly under Mn-supplemented conditions, confirming effective cofactor incorporation.
• Galactose was consumed and converted to UDP-galactose intracellularly, demonstrating active substrate conversion.
• Glycan analysis revealed enhanced levels of monogalactosylated (G1F) and digalactosylated (G2F) structures in the +Mn/+Gal condition, maintained even in stationary phase.

Benefits and Practical Applications

• The integrated analytical platform enables a detailed understanding of glycosylation modulation factors.
• Multicomponent monitoring supports the rational design of culture conditions to tailor therapeutic antibody glycan profiles.

Future Trends and Possibilities

• Extension to additional glycosyltransferase substrates and cofactors for broader glycan engineering.
• Integration with metabolomic and proteomic data to refine bioprocess control strategies.
• Application of high-throughput screening workflows for rapid optimization of glycosylation patterns.

Conclusion

Comprehensive analysis of sugars, metal cofactors, sugar nucleotides, and glycans elucidates the mechanistic basis for glycan profile control in CHO cell cultures. Manganese and galactose supplementation effectively enhance galactosylation, offering a strategic route to optimize antibody quality attributes.

References

1. Wang Z., Zhu J., Lu H. Antibody Glycosylation: Impact on Antibody Drug Characteristics and Quality Control. Applied Microbiology and Biotechnology. 2020;104(5):1905–1914.
2. Shimadzu Application News: Analysis of Metal Elements in Culture Medium Using ICPMS-2050 (01-00712).